The reasons for triple therapy in stable COPD patients in Japanese clinical practice

BACKGROUND: Triple combination therapy involving long-acting muscarinic antagonists long-acting β(2) agonists, and inhaled corticosteroids has recently become an option for maintenance treatment of COPD. Some add-on clinical trials have reported the benefits of these combinations. However, the proce...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Miyazaki, Masaki, Nakamura, Hidetoshi, Takahashi, Saeko, Chubachi, Shotaro, Sasaki, Mamoru, Haraguchi, Mizuha, Terai, Hideki, Ishii, Makoto, Fukunaga, Koichi, Tasaka, Sadatomo, Soejima, Kenzo, Asano, Koichiro, Betsuyaku, Tomoko
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4461139/
https://ncbi.nlm.nih.gov/pubmed/26082629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S79864
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars